微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | -11.5% | -192.62% | -63.12% | 141/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | -7.05% | -265.29% | -257.87% | 137/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | -1.97% | -432.43% | 61.67% | 134/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | -5.14% | -1.38% | -30.79% | 112/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | -3.93% | -275.45% | -103.63% | 125/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -1.93% | -245.11% | -421.62% | 122/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -0.37% | -131.09% | 92.7% | 115/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -5.07% | -190.21% | -326.34% | 113/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 2.24% | -51.09% | 68.42% | 98/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.33% | -51.28% | 11.76% | 97/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.19% | -4.8% | -78.83% | 87/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 5.62% | 7.87% | 22.71% | 57/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.58% | 33.14% | 67.77% | 75/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.73% | 34.48% | 118.4% | 71/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.25% | -1.57% | -76.01% | 78/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 5.21% | 90.15% | 51.45% | 74/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.44% | 12.05% | 69.46% | 79/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.03% | -19.44% | 59.84% | 84/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.27% | -9.93% | -53.65% | 81/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 2.74% | -74.56% | -10.75% | 93/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 3.07% | -72.61% | 21.83% | 95/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.52% | -74.07% | 78.72% | 87/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.41% | 2% | -86.91% | 83/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 10.77% | -44.88% | -3.93% | 48/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 11.21% | 2% | 15.33% | 31/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 9.72% | -6.54% | -50.26% | 21/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | 19.54% | 26.23% | 87.88% | 20/159 | 2.62% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-06-30 | 10.4% | 2% | -32.82% | 13/159 | 5.02% | 誉衡药业 | 35.56% | 行业排名> |
| 2018-12-31 | 15.48% | 50.29% | 50.29% | 28/159 | 7.16% | 奥赛康 | 35% | 行业排名> |
| 2017-12-31 | 10.3% | -38.62% | -38.62% | 46/159 | 9.61% | 奥赛康 | 28.15% | 行业排名> |
| 2016-12-31 | 16.78% | 2% | 2% | 31/159 | 6.11% | 宏源药业 | 21.91% | 行业排名> |